Evaluation study on the clinical efficacy of nerve function defect in patients with vascular dementia (deficiency, blood stasis and deficiency of liver-yang syndrome) by shenma yizhi decoction

Evaluation study on the clinical efficacy of nerve function defect in patients with vascular dementia (deficiency, blood stasis and deficiency of liver-yang syndrome) by Shen-ma Yi-zhi decoction

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017359

Enrollment

Unknown

Registered

2018-07-25

Start date

2018-07-26

Completion date

Unknown

Last updated

2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular dementia

Interventions

Group 1:Traditional Chinese Medicine Shenma Yizhi Decoction

Group 2:analogue of Shenma Yizhi Decoction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN) criteria, guidelines for the treatment of senile dementia by traditional Chinese medicine, issued by the Ministry of Health(2002).

Exclusion criteria

Exclusion criteria: Exclusion the following disease, including sencephalitis, epilepsy, Parkinson's disease, trauma, or other diseases cause of dementia and severe liver and kidney system disease.

Design outcomes

Primary

Measure	Time frame
scales of TCM syndrome;neuropsychological tests;Hs-CRP;NSE;Hcy;	—

Countries

China

Contacts

Public ContactYun Wei

Xiyuan Hospital, China Academy of Traditional Chinese Medicine

weiyun_0913@163.com+86 010 62835088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026